Wednesday, May 24, 2017
Modified experimental vaccine protects monkeys from deadly malaria.
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight monkeys that received it against challenge with the virulent Plasmodium falciparum malaria parasite. In three of the remaining four monkeys, the vaccine delayed when parasites first appeared in the blood by more than 25 days.Malaria symptoms occur when parasites replicate inside red blood cells and cause them to burst. full story.